Location: New York, NY
CIK: 0001822947 · Show all filings
Period: Q2 2021 (← Previous) (Next →)
Filing Date: Aug 16, 2021
Total Value: $403M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | MEDAVAIL HOLDINGS INC | 2,920,780 | $35.78M | 8.9% | $15.05 | — | COM | 58406B103 |
| — | SPDR SER TR | 200,000 | $27.08M | 6.7% | — | — | Put | 78464A950 |
| NTRA | NATERA INC | 218,000 | $24.75M | 6.1% | $87.13 | +17.4% | COM | 632307104 |
| FATE | FATE THERAPEUTICS INC | 270,000 | $23.43M | 5.8% | $63.35 | +27.2% | COM | 31189P102 |
| — | APELLIS PHARMACEUTICALS INC | 300,000 | $18.96M | 4.7% | — | — | Call | 03753U906 |
| — | SYROS PHARMACEUTICALS INC | 3,439,895 | $18.75M | 4.7% | $9.89 | — | COM | 87184Q107 |
| ARVN | ARVINAS INC | 240,000 | $18.48M | 4.6% | $54.99 | +26.2% | COM | 04335A105 |
| — | CEREVEL THERAPEUTICS HLDNG I | 675,670 | $17.31M | 4.3% | $16.58 | — | COM | 15678U128 |
| RGEN | REPLIGEN CORP | 82,500 | $16.47M | 4.1% | $181.94 | +6.6% | COM | 759916109 |
| NUVB | NUVATION BIO INC | 1,708,091 | $15.9M | 4.0% | $11.18 | +2.0% | COM CL A | 67080N101 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 859,910 | $15.73M | 3.9% | $18.39 | -6.9% | COM | 92790C104 |
| — | MIRATI THERAPEUTICS INC | 95,000 | $15.35M | 3.8% | $161.53 | — | COM | 60468T105 |
| NAUT | NAUTILUS BIOTECHNOLOGY INC | 1,500,000 | $15.15M | 3.8% | $10.83 | 0.0% | COM | 63909J108 |
| NTLA | INTELLIA THERAPEUTICS INC | 93,127 | $15.08M | 3.7% | $36.31 | +114.4% | COM | 45826J105 |
| — | CYTEIR THERAPEUTICS INC | 626,843 | $13.41M | 3.3% | $21.40 | — | COM | 23284P103 |
| COGT | COGENT BIOSCIENCES INC | 1,622,591 | $13.16M | 3.3% | $10.99 | -23.1% | COM | 19240Q201 |
| — | NANOSTRING TECHNOLOGIES INC | 185,000 | $11.99M | 3.0% | $64.79 | — | COM | 63009R109 |
| IDYA | IDEAYA BIOSCIENCES INC | 510,407 | $10.71M | 2.7% | $20.47 | +0.4% | COM | 45166A102 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 406,986 | $10.59M | 2.6% | $39.90 | -34.9% | COM | 462260100 |
| — | ESSA PHARMA INC | 363,185 | $10.38M | 2.6% | $25.37 | — | COM NEW | 29668H708 |
| — | INVITAE CORP | 300,000 | $10.12M | 2.5% | $33.73 | — | COM | 46185L103 |
| GOSS | GOSSAMER BIO INC | 1,175,000 | $9.541M | 2.4% | $8.67 | 0.0% | COM | 38341P102 |
| AVIR | ATEA PHARMACEUTICALS INC | 373,288 | $8.018M | 2.0% | $32.23 | -6.8% | COM | 04683R106 |
| — | BOLT BIOTHERAPEUTICS INC | 412,267 | $6.374M | 1.6% | $27.64 | — | COM | 097702104 |
| APLS | APELLIS PHARMACEUTICALS INC | 85,000 | $5.372M | 1.3% | $42.30 | +22.0% | COM | 03753U106 |
| — | ADICET BIO INC | 425,000 | $4.373M | 1.1% | $13.08 | — | COM | 007002108 |
| SPRY | SILVERBACK THERAPEUTICS INC | 128,572 | $3.972M | 1.0% | $33.40 | -4.0% | COM | 82835W108 |
| — | FREELINE THERAPEUTICS HLDGS | 401,747 | $3.274M | 0.8% | $18.26 | — | SPONSORED ADS | 35655L107 |
| MGNX | MACROGENICS INC | 112,839 | $3.031M | 0.8% | $29.29 | 0.0% | COM | 556099109 |